Connection

Evangelos Terpos to Immunologic Factors

This is a "connection" page, showing publications Evangelos Terpos has written about Immunologic Factors.
Connection Strength

0.055
  1. The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents. Blood. 2018 01 25; 131(4):464-467.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.